Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-65,900
Closed -$3.8M – 3653
2024
Q3
$3.8M Buy
65,900
+16,100
+32% +$869K 0.01% 1086
2024
Q2
$2.42M Buy
49,800
+15,500
+45% +$748K 0.01% 1360
2024
Q1
$1.67M Sell
34,300
-24,000
-41% -$1.17M ﹤0.01% 1597
2023
Q4
$2.9M Buy
58,300
+10,400
+22% +$509K ﹤0.01% 1379
2023
Q3
$2.57M Buy
+47,900
New +$2.55M ﹤0.01% 1339

Other funds holding SNY

GTS Securities's SNY Position: Q2 2026 in Review

GTS Securities opened a new position in Sanofi (SNY) in Q2 2026: 18,059 shares worth $770K. The stake represents 0.02% of the portfolio and ranks #539 among its holdings. This is a return to the name: GTS Securities previously reported a position in SNY as recently as Q1 2025.

GTS Securities first reported a position in SNY in Q2 2023 and has held it in 8 quarters since. The position peaked at $5.99M in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • GTS Securities held 18,059 shares of Sanofi worth $770K as of Q2 2026.
  • Sanofi was a new GTS Securities position in Q2 2026.
  • Sanofi made up 0.02% of GTS Securities's portfolio in Q2 2026, its #539 holding.
  • GTS Securities first reported a position in Sanofi in Q2 2023 and has held it in 8 quarters since.
  • GTS Securities's Sanofi position peaked at $5.99M in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.